Cargando…
Endocannabinoid system mediates the association between gut-microbial diversity and anhedonia/amotivation in a general population cohort
Anhedonia and amotivation are debilitating symptoms and represent unmet therapeutic needs in a range of clinical conditions. The gut-microbiome-endocannabinoid axis might represent a potential modifiable target for interventions. Based on results obtained from animal models, we tested the hypothesis...
Autores principales: | Minichino, Amedeo, Jackson, Matthew A., Francesconi, Marta, Steves, Claire J., Menni, Cristina, Burnet, Philip W. J., Lennox, Belinda R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760063/ https://www.ncbi.nlm.nih.gov/pubmed/34002020 http://dx.doi.org/10.1038/s41380-021-01147-5 |
Ejemplares similares
-
The gut-microbiome-endocannabinoid axis and anhedonia/amotivation: A mediation analysis in a general population cohort
por: Minichino, A., et al.
Publicado: (2021) -
S7. INVESTIGATING THE LINK BETWEEN THE PERIPHERAL ENDOCANNABINOID SYSTEM AND CENTRAL GLUTAMATERGIC NEUROTRANSMISSION IN EARLY PSYCHOSIS: A 7T-MRS STUDY
por: Minichino, Amedeo, et al.
Publicado: (2020) -
Neural Basis of Anhedonia and Amotivation in Patients with Schizophrenia: The role of Reward System
por: Lee, Jung Suk, et al.
Publicado: (2015) -
Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis
por: Safadi, Jenelle Marcelle, et al.
Publicado: (2021) -
T175. THE GUT-MICROBIOTA AS A TARGET FOR THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CONTROLLED TRIALS OF ADD-ON STRATEGIES
por: Minichino, Amedeo, et al.
Publicado: (2020)